| COVID-19 |
1 |
0.96 |
| Clinical Research |
0 |
0.86 |
| Pandemic |
0 |
0.75 |
| COVID-19 Vaccine |
0 |
0.71 |
| Healthcare and Medical Technology |
0 |
0.63 |
| Herpes Zoster |
0 |
0.26 |
| Health Administration |
0 |
0.25 |
| Vaccines |
0 |
0.24 |
| Medical Innovations |
0 |
0.23 |
| Health Care Services |
0 |
0.12 |
| Genomic Medicine |
0 |
0.08 |
| Allergy |
0 |
0.06 |
| Artificial Intelligence |
0 |
0.06 |
| Cancer |
0 |
0.06 |
| Clinical Guidelines |
0 |
0.06 |
| Diversity |
0 |
0.06 |
| Epidemiology |
0 |
0.06 |
| Food and Drug Administration (FDA) |
0 |
0.06 |
| Geriatrics |
0 |
0.06 |
| Hospital |
0 |
0.06 |
| Jobs |
0 |
0.06 |
| Outbreak |
0 |
0.06 |
| Plasma |
0 |
0.06 |
| Preventive Medicine |
0 |
0.06 |
| Professional Development |
0 |
0.06 |
| Social Determinants of Health |
0 |
0.06 |
| Technology Transfer |
0 |
0.06 |
| Therapeutic Vaccine |
0 |
0.06 |
| Varicella-Zoster Virus |
0 |
0.06 |